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Abstract: 
Background: Lung cancer is the most common cancer and cause of death worldwide. Almost 50 percent of lung 
cancer cases are found in the developing countries. The estimated numbers of new lung cancer cases in the Arab 
world show a gradual increase every year. Cancer lung and its treatment modalities increase incidence of fatigue. 
Many studied documented that patients with cancer related fatigue described it as more distressing than other 
cancer-related symptoms such as pain, depression, and nausea. Correction of anemia, exercises, dietary 
supplements rich in vitamins specially beta-carotene, yoga, complementary and alternative medicine have been 
suggested as strategies/ guidelines of managing fatigue. Natural nutritional supplementations were recommended 
by oncologists, nurse specialists, as well authors in the field of applied nutrition and they recommend juicing 
fruits and vegetables. One of the recommended formulas for fighting fatigue consisted of carrot, beetroot, mixed 
with celery juice (energy juice). Carrot juice is known as a miracle juice as it removes bacterial infection, 
beetroot act as anti cancer factor as well as powerful blood detoxifying agent and celery juice is a source of folic 
acid, vitamin B1&6.  
Aim of the Study: Was to identify the effect of the nutritional formula on fatigue among lung cancer patients at 
a University Hospital-Egypt. 
Design: Time series longitudinal comparative study. 
Research questions: 1-a-What is the effect of the nutritional formula on fatigue among patients with advanced 
lung cancer before and after receiving chemotherapy? 
1-b- Is there a difference between fatigue scores on the start of using the formula and at the end of rehydration 
period among patients with advanced cancer lung receiving chemotherapy? 
2-a-Is there a relation between fatigue score prior and after taking the nutritional formula and 
the selected medical outcome (duration of illness, hemoglobin, WBCs)? 
2-b-Is there a relation between fatigue score prior and after taking the nutritional formula and patients' age, 
metastasis occurrence and chemotherapy medication? 
Sample: A convenient sample of thirty patients with advanced lung cancer receiving chemotherapy was 
collected over a year. Two tools were used to collect data; Demographic & Medical data assessment sheet and 
the Revised Piper Fatigue Scale (PFS-R13).  Data were collected before receiving chemotherapy (on admission), 
one day after receiving chemotherapy (beginning of using the nutritional formula), after rehydration period (one 
week later), two weeks later & before discharge).  
Results: Fatigue scores increased after receiving chemotherapy and began to decrease gradually after 
rehydration period, so there was a significant statistical difference between fatigue scores measured before and 
after the use of the nutritional formula. And there is a statistical significant difference over the four readings of 
fatigue scores reading and the selected medical responses (duration of illness Hgb 1st reading & 2nd reading, 
WBCs 1st reading), age.  
Conclusion: The suggested nutritional formula helped in decreasing fatigue among lung cancer patients 
receiving chemotherapy. 
Key words: Fatigue, cancer lung, chemotherapy, nutritional values (Carrots, celery, parsley). 
 
 
Introduction: 
 
        Lung cancer was considered to be rare in the beginning of the 20th century but has now reached almost 
epidemic proportions (ABID, 2011). In 2008 it was the most commonly diagnosed cancer worldwide in males 
and the fourth among females, as well as the most leading cause of cancer death in males and the second among 
females (Jemal, Bray, Center, Ferlay, Ward & Forman, 2011 & ABID, 2011). Lung cancer accounts for 13% 
(1.6 million) of the total cases and 18% (1.4 million) of the deaths in 2008 (Salim, Jazieh and Moore, 2011) and 
it raised to three million per year by the year 2010 based on the GLOBOCAN, (2008) estimates. Global 
incidence of lung cancer is increasing at 0.5% per year (ABID, 2011 & American Cancer Society; 2011). 
Although the median overall incidence and mortality rates of lung cancer in the Arab world is one of the lowest 
in the world the forth coming prediction of estimated numbers of new lung cancer cases in the Arab world show 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
18 
a gradual increase every year because of population growth, aging, increased smoking prevalence particularly in 
youth and women, as well as increased exposures to environmental pollutants in the region may play a critical 
role (Salim, Jazieh & Moore, 2011). 
 
Regarding symptoms of cancer lung, many authors as; Abdel Qader in Ramadan (2012) & ABID 
(2011) &  Alaa, etal, (2010) claimed that lung cancer is typically asymptomatic in its early stages of 
development, and even when symptoms appear, they are usually nonspecific. Consequently, American Cancer 
Society (2011) explained that symptoms of lung cancer are nonspecific as they may include persistent cough, 
sputum streaked with blood, chest pain, voice change, and recurrent pneumonia or bronchitis. Based on these 
facts Salim, Jazieh & Moore (2011) stated that the prognosis of lung cancer is very poor as the majority of lung 
cancer patients are diagnosed after the disease has progressed to a more advanced stage. The effect of smoking is 
a probable reason for poor survival among lung cancer patients. There is some evidence that smoking-related co-
morbidities such as cardiovascular diseases or chronic obstructive pulmonary disease may have an additional 
negative impact on survival as well current or previous smoking reduces the effectiveness of radiotherapy or 
chemotherapy when treating lung cancer (ABID, 2011). 
 
      Fatigue is one of the most prevalent symptoms experienced by cancer patients (Cella, etal, 2001). Moreover, 
up to 90% of lung cancer patients experienced acute fatigue before and after cancer treatment (Hofman, Ryan, 
Figueroa-Moseley, Jean-Pierre & Morrow, 2007) and also later, in the terminal or survival phase of the illness 
(Collin, de Voge-Voogt, Visser & Van der Heide, 2008). This pervasiveness of fatigue in the cancer experience 
has suggested to coin the term “cancer-related fatigue” (CRF), as recommended by healthcare providers in 2003 
for its systematic and accurate assessment (NCCN, 2009 & Piper, Borneman, Sun, Koczywas , Uman, Ferrell & 
James, 2008).  Cancer-related fatigue (CRF) was defined by The National Comprehensive Cancer Network 
(NCCN) as: "a persistent, subjective sense of tiredness related to cancer or cancer treatment that interferes with 
usual functioning (American Cancer Society, 2003). Fatigue associated with cancer is not the kind that will 
disappear after taking a nap or get a good night's sleep, but tends to be more severe and ongoing (Morrow, 2005 ; 
Intercultural Cancer Counsel, 2008). Patients reported that CRF is more distressing and has a greater impact than 
other cancer-related symptoms such as pain, depression, and nausea (Morrow, 2007). The impact of fatigue is 
profound and affects the ability to work, walk short distances, be intimate and meet the families' needs. There is 
difficulty when performing even the simplest tasks such as cooking, cleaning, or taking a shower, making 
relatively simple decisions as well difficulty in concentrating. CRF also affects cancer treatment as it may 
compromise the timing or completion of treatment regimens either because fatigue is a dose-limiting, adverse 
effect or because it reduces the patient's willingness to adhere to treatment (Hofman, Ryan, Figueroa-Moseley, 
Jean-Pierre, & Morrow, 2007). Moreover, CRF is not predictable by tumor type, treatment, or stage of illness. 
Usually; it comes on suddenly, does not result from activity or exertion, and is not relieved by rest or sleep 
(Medicine, 2013). This impact is magnified by the increasing life expectancy of people with cancer and by the 
persistence of CRF for months—or even years—after the end of cancer treatment (Amen, 2010 & ICC 2008 & 
Morrow, 2007). 
 
Cancer-related fatigue is a multi-factorial, multidimensional phenomenon which consists of physical, 
psychological, social, cognitive, and behavioral aspects (Servaes, Verhagen and Bleijenberg, 2002). The exact 
cause of cancer-related fatigue is unknown as it may be related to the disease itself (Gutstein,  2001) or its 
treatments including chemotherapy, radiotherapy, combination of both or biological therapy (Medicine, 2013). 
The pathogenesis of fatigue related to receiving   chemotherapy involves its effects on the central nervous 
system, muscle energy metabolism, sleep or circadian rhythms (Parker, Bliwise, Ribeiro, et al., 2008), mediators 
of inflammation and stress (Cleeland, Bennett , Dantzer et al., 2003), immune activation (Collado-Hidalgo, 
Bower, Ganz et al., 2006 & Scott , McMillan , Brown et al, 2002) and hormonal changes related to effects on the 
hypothalamic–pituitary axis, premature menopause in women (Fan, Houe´ de´ -Tchen Yi  et al. 2005), or 
androgen deprivation in men (Ryan, Carroll, Ryan et al. 2007).  On the other hand, the National Comprehensive 
Cancer Network (NCCN) (2004) published the fact that seven factors are identified as frequently contributing to 
cancer-related fatigue: pain, emotional distress, sleep disturbance, anemia, nutritional deficiencies, 
deconditioning, and co-morbidities. Adding that, if none of these seven factors can be identified as being present, 
a comprehensive assessment is indicated, including a careful review of systems, evaluation of disease status, and 
review of current medications. Another study found that anemia and lack of sleep have both been strongly 
associated with onset of fatigue (Ahlberg, Ekman, Gaston-Johansson, & Mock, 2003). Older studies proved that 
fatigue is associated with the development of physical side effects of chemotherapy such as nausea, change in 
taste, mouth sores, chills, and vomiting (Jacobsen, Haan, Azzarello, Horton, Balducc & Lyman, 1999). On the 
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other hand, NCCN (2012) and Cancer Research UK (2012) claimed that cancer lung and other cancers that affect 
breathing are causes of fatigue. 
  
      Mock (2004) & Iop, Manfredi & Bonura (2004) stated that potentially useful treatments for cancer-related 
fatigue (CRF) can be classified into two main aspects pharmacological and non pharmacological. The 
pharmacologic interventions include erythropoietin for chemotherapy-induced anemia, correcting metabolic 
disorders; other cause-specific treatments such as antidepressants when depression is a cause of fatigue, and 
psycho- stimulants to help patients feel energized and less fatigued. Preliminary evidence from clinical trials of 
erythropoietin in anemic patients with nonmyeloid malignancies receiving chemotherapy indicates that increases 
in hemoglobin levels are reflected in improved energy and physical functioning, decreased fatigue, and increased 
quality of life. While, the non pharmacologic interventions for cancer-related fatigue  include exercise and sleep 
therapy, behavioral therapy to modify sleep , and psychosocial support programs,  cognitive therapy and coping 
strategies to reduce stress and conserve energy as well as nutritional support. These interventions were supported 
by Cancer Research UK (2012) and Carroll, Kohli , Mustian, et al ( 2007) also, mindfulness relaxation, and yoga 
were suggested by (Jean-ierre,  Mustian, Kohli , et al. 2006). 
 
     World Cancer Research Fund (WCRF), (2007) issued a comprehensive report on the effects of foods and 
nutrients on the risk of cancer, based on systematic literature reviews commissioned from around the world, 
judged by 21 experts on nutrition and cancer. After careful adjustment for tobacco use history, the WCRF 
concluded there was an approximate 20% increased risk for incident lung cancer among those in the lowest 
quintile of fruit intake. These conclusions are consistent with the previously published conclusions of an expert 
panel convened by the American Cancer Society (ACS). The panel recommended to eat at least two servings of 
fruits containing vitamins specifically pro–vitamin A (antioxidant beta-carotene) each day would likely lead to 
reduced risk for lung cancer. They also reported that oral vitamin A & E supplementation might reduce risk of 
lung cancer and considered one of the main guidelines for better recovery of those patients as those vitamins are 
anticancer, antioxidants, but they claimed that vitamin A & E should be given through natural resources as 
parentral with smoking may precipitate cancer factors. Consequently many authors, nurse practitioners, oncology 
institutes proposed dietary guidelines and formulas aiming to improve the condition of patients with cancer 
treated with cytotoxic drugs. The highly recommended diet for those poor patients was that contain beta-
carotenes. Formulas in the form of juices were recommended than steamed or completely cooked formulas. 
Apple, carrot, beetroots, celery, parsley, spinach were mentioned by many authors such as Coleman, (2012) and 
Evans, (2010), Eldridge, (2009) & Opptiz, (2008). The exact effect of the proposed formulas is not documented 
although many authors call them the energy juices and recommend it, thus this study was conducted to 
investigate the effect of natural formula on fatigue among patients with lung cancer who are treated with 
chemotherapy.    
 
Significance of the study: 
 
       The researchers of the present study observed that many patients with cancer lung who are receiving 
chemotherapy in the inpatient floors of the Oncology and Nuclear Medicine unit at Kaser Al-Einy hospital 
refused to eat their meals either offered from hospital or from home. When interviewing those patients they 
reported that they found difficulties when eating any type of food because of dyspnea they claimed "either eat or 
breath", also they mentioned that the offered meals need chewing while they are easy fatigue. Adding  that the 
unit offers to them caned beverage and juice which preferable to them to increase their energy, while the families 
of those patients (caregivers) were afraid that the patients' refusal of eating different food staff may lead to 
discontinuity of chemotherapeutic treatment plan. Those caregivers reported that some of their patients were 
ineligible for receiving chemotherapy and sessions were postponed. On the other hand, the researchers observed 
lately that fatigue is used as a medical diagnosis that indicates hospitalization among patients receiving 
chemotherapy, but there was no statistical support for that new termed medical diagnosis.  
 
       The National Cancer Institute (2010) reported that patients with lung cancer experienced fatigue because of   
the nutrition factor as fatigue often occurs when the body needs more energy than the amount being supplied 
from the patient's diet. In people with cancer, three major factors may be involved: a change in the body's ability 
to process food normally, an increased need by the body for energy (due to growth, infection, fever, or problems 
with breathing) and a decrease in the amount of food eaten (due to lack of appetite, nausea, vomiting, or 
intestinal obstruction) which ended up by anemia. Years of 2009 & 2010 were 177 & 154 respectively 
(Consensus of Oncology and Nuclear Medicine unit, Cairo University) of patients with lung cancer. 
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       Many nursing studies documented the phenomenon of cancer related fatigue, such as the study which carried 
out by Abdel Raouf & Hashem (2005) who documented that fatigue was reported by 82% of the cancer patients 
as it's the second cancer problem priority for patients with different cancer lesion receiving chemotherapy, while 
few studies enclose some guidelines that might help in reducing that fatigue such as correction of anemia, 
practice exercises, proper sleep…etc. The researchers of the present study believed in two issues; the first is that 
nutritional plan is one of the major nurses' responsibilities even if the prognosis of the patients is poor and the 
second issue is; fatigue management is crucial role of the nurses to help patients to live with less pain, miniature 
discomfort and even to die with dignity. 
 
Hopefully that this study will highlight the needs of those patients as well as help such poor patients 
with dietary guidelines helping to fight cancer treatment side effects. Also it is hoped that such study help in 
building the body of nursing knowledge, encourage nursing researchers to investigate other formula and find out 
helpful nutritious guidelines for patients with lung cancer and other cancer lesions. 
 
Operational Definitions: 
 
-Nutritional formula/(Energy Juice): Its ingredients are one small beetroot (the small ones are sweeter), two to 
three medium sized carrots and one stalk of celery. Patients take it twice daily. The (Energy Juice) ingredients 
were approved by Opptiz (2008). Also formula was approved by many authors as Presely (2011), Nelson (2010), 
Monson (2008), and Whitney-Chavez (2011). 
  
-Rehydration period/phase: The starting phase of giving the nutritional formula (Energy Juice) in addition to 
the recommended routine intravenous fluid based on the physician description which started after administering 
the chemotherapy for cancer lung patients. 
  
-Selected medical responses: Hemoglobin (Hgb), white blood cells (WBCs) & duration of illness. 
  
Aim of the study: 
 
     The aim of this study was to identify the effect of the nutritional formula on fatigue among lung cancer 
patients at a University Hospital-Egypt. 
 
Research questions: 
 
1-a-What is the effect of the nutritional formula on fatigue among patients with advanced cancer lung before and 
after receiving chemotherapy? 
1-b- Is there a difference between fatigue scores on the start of using the formula and at the end of rehydration 
period (before discharge from hospital) among patients with advanced cancer lung receiving chemotherapy? 
 
2-a-Is there a relation between fatigue score prior and after taking the nutritional formula and 
the selected medical outcome (duration of illness, hemoglobin, WBCs)? 
2-b-Is there a relation between fatigue score prior and after taking the nutritional formula and patients' age, 
metastasis occurrence and chemotherapy medication? 
  
2. Subjects & Method: 
 
 Design: 
Time series longitudinal comparative study was utilized in this study. 
 
Setting: 
    The study was conducted at the inpatient floors in the Oncology and Nuclear Medicine unit at Kasr 
Al-Einy hospital-Cairo University-Egypt. The inpatients floors are two which contain 50 beds for adults and 14 
for children. Patients with advanced lung cancer always receive their chemotherapy at the inpatient department 
as their protocol of care include receiving either platinol or Fluorouracil; administration of oxygen in addition. 
Many of those patients stay for two weeks or more as they mostly experienced anemia, severe fatigue, recurrent 
vomiting, severe diarrhea & fluid and electrolytes imbalance until those problems subside then discharged till the 
date of the following session of chemotherapy according to their protocol of treatment.  
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Sample:  
       A total of 34 adult male and female patients with confirmed diagnosis of advanced lung cancer receiving 
chemotherapeutic agents intravenously in the Oncology and Nuclear Medicine inpatient unit at kaser El Einy 
hospital Cairo university. Data collection was over one year (from October 2010 to September 2011) constituted 
the study subjects. 4 patients were excluded during the different phases of the study because of metastasis to the 
brain and inability to come to the hospital. In addition patients who discontinued receiving chemotherapy more 
than once; so finally 30 patients continued till the end of the study. The 30 patients' age ranged between 20-64 
years old. 
  
Exclusion criteria were patients on mechanical ventilator as they have special total parental therapy, patients 
who dislike the formula taste as well as patients with other health problem that may provoke fatigue, patients 
with brain metastasis.  
 
Tools:  
Data of this study was collected by using the following tools: Demographic & Medical Assessment 
Sheet and the Revised Piper Fatigue Scale (PFS-R13).    
 
 1- Demographic & Medical Background Assessment Data Sheet: was developed by the researchers based on 
review of literature, it included three parts: the first part includes demographic data; age, gender, occupation and 
residence; the second part includes data related to medical background namely; patients’ diagnosis (primary/ 
metastasis), duration of illness, name of chemotherapeutic agent, cycle number and session number. The third 
part includes data related to administration of chemotherapy intravenously and the date of obtaining these data. It 
includes blood picture results (hemoglobin and white blood cells count), presence of vomiting and diarrhea. 
 
2- Revised Piper Fatigue Scale (PFS-R13): is a multidimensional instrument useful in fatigue assessment 
originating from a prior longer version of the scale  (Dittner, Wessely & Brown, 2004) & (Piper, Dibble, Dodd, 
Weiss, Slaughter & Paul 1998). The scale consists of 22 items supplemented by 5 additional open-ended 
questions related to the temporal dimension of fatigue, its perceived cause, effect, relief, and additional 
symptoms not included in the scoring but are recommended to be kept on the scale as these items furnish rich, 
qualitative data. A principal component factor analysis groups the 22 items into 4 reliable and correlated 
dimensions: behavioral/ severity (6 items from2 to 7), relating to the severity and degree of disruption in activity 
of daily living; affective meaning (5 items from 8 to 12), relating to the emotional meaning attributed to fatigue; 
sensory (5 items from 13 to 17), relating to the physical symptoms; and cognitive / mood (6 items from 18 to 
23), relating to mental and mood states. Scaling is based on a 0-10 range; total and subscale mean scores are 
derived from summing individual items and dividing by the number of items in the subscale/total scale to 
maintain the 0-10 scaling. Scoring system: To calculate the total fatigue score, add the 22- item scores together 
and divide by 22 in order to keep the score on the same numeric "0" to "10" scale. Severity Codes: 0=None; 1-
3=Mild; 4-6=Moderate; 7-10= Severe. All the twenty two items=220, or by using the logic rule (1-3=Less than 
73 Mild fatigue, 4-6= 73- to less than 146 Moderate fatigue, 7-10= 146-220 Severe fatigue). Other total scores 
calculation which divided the patients' feeling into good and bad. Patients who have score less than 110 consider 
(feeling good). While patients who have score 110 up to 220 consider (feeling bad). Piper, Dibble, Dodd, Weiss, 
Slaughter & Paul (1998).  
 
The PFS-R13 demonstrated strong internal consistency reliability and construct validity (Clark, 
Ashford, Burt, Aycock and Kimble, 2006 & Annunziata, Muzzatti, Mella, Narciso, Giacalone, Fratino & Tirelli, 
2010). Piper Fatigue Scale scores reliability was with (r = 0.80); high internal consistency (alpha= 0.98) and 
strong test-retest agreement (intraclass correlation coefficient = 0.98). (Strohschein , Kelly, Clarke, Westbury, 
Shuaib , Chan , 2003) The tool takes seven to ten minutes to be filled. This tool was translated into Arabic and 
tested for validity by Abo Daif (2004) on the study of correlates of fatigue among patients with chronic airway 
limitations. 
 
The Nutritional formula (Energy Juice): 
  
Components: one small beetroot (the small ones are sweeter), two to three medium sized carrots and 
one stalk of celery. Formula was suggested by Opptiz (2008). Also ingredients was approved by many authors as 
Presely (2011), Nelson (2010), and Monson (2008), and other authors such as Whitney-Chavez  (2011) who 
mentioned that beetroot, carrot and celery are low in calories and contain no fat or cholesterol, also another 
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benefit was mentioned by Juice Therapy, This formula overcomes both kidney and liver problems and called as 
(Energy Juice). 
 
Preparation:  
Juice together in the order given; stir the juice to mix the flavors. 
  
Amount:  
Patients were advised to take it twice daily on an empty stomach. Vegetable juice is very perishable so 
it is best to drink all of the prepared juice immediately. To store the juice: Put juice in a glass jars with an airtight 
lid and fill it to the very top. There should be a minimum amount of air in the jar as the oxygen in air will oxidize 
and damage the juice. Wrap the jar with aluminum foil to block out all light. Light damages the juice. Store it in 
the refrigerator until about 30 minutes prior to drinking, as vegetable juice should be consumed at room 
temperature. The juice can be stored for up to 24 hours with only moderate nutritional decline (Opptiz, 2008). 
 
Benefits of the formula ingredients (Energy Juice): 
Beetroots: The best way to enjoy the nutritional value of beets is by drinking freshly extracted raw beet 
juice. The juice of raw beetroot contains a host of health benefits, and is classed as a" super food” in today’s 
nutritional jargon (Evans, 2010 & Coleman, 2012). The more important benefits of beet juice are: 1) 
Antioxidants as it can help reduce the oxidation of LDL cholesterol which could lead to damaged artery walls 
and ultimately heart attacks and strokes. Help in lower hypertension.  2) Anti-carcinogenic as the deep red color 
of beetroot comes from betacyanin which prevents from cancer specially cancer colon. 3) Vitamins source 
as beetroots are a good source of folic acid and vitamin C. It also contains small amounts of vitamins B1, B2, 
B3, and vitamin A in the form of beta-carotene. Consequently increase the oxygen-carrying ability of the blood 
by up to 400 per cent. 4) Rich in minerals such as calcium, magnesium, phosphorus, potassium, and sodium. 
Also, smaller amounts of iron, zinc, copper, manganese, and selenium. 5) Provide small amounts of all the 
amino acids. 6) Contain Silica which help in perfect utilization of calcium in the body and is also required for 
healthy skin, hair, nails and bones. 7) Provide calories as one (5cm) beetroot contains 35 calories. 8) detoxifies 
the liver as it encourages liver cleansing, improves liver functioning. (Evans, 2010 & Agro, 2008). 
 
Carrot: Carrot juice is known as a miracle juice. Of the many vitamins in the carrot juice the most 
important is Vitamin A and next is Vitamin E. It is present in three chemical forms – alpha, beta and gamma to 
co-pherrol which are collectively known as Vitamin E. complex. Carrots contain the cartenoid alpha carotene, 
beta-carotene and potent antioxidants. Recent studies published in the "Antioxidant Miracle," indicate that alpha 
carotene is a more potent cancer preventative and fighter than even beta-carotene. Carrots contain one of the few 
cartenoids with pro Vitamin A activity, which means that the body converts the beta-carotene into Vitamin A as 
needed. In addition, carrots contain calcium pectate, a source of soluble fiber, Vitamin B-complex, C, D, E and 
K, iron, calcium and phosphorous and manganese (Connell, 2011). According to the "Antioxidant Miracle," 
carrot juice provides powerful antioxidants that support health and the immune system. The advantages of 
having carrot juice was summarized by Oppitz (2008) the nurse working in Itasca Naturopathic Clinic as follow: 
eliminates toxins, aids digestion, improves and maintains bone and teeth, improves muscle tone, helps prevent 
infections of respiratory organs, reduces ulcerous and cancerous conditions, helps protect the nervous system,  
increases vitality, and restores normal responsiveness to adrenal glands. Moreover, carrot can be used to treat the 
following: anemia, cancer, acidosis, atherosclerosis, upper respiratory congestion, emphysema, constipation, 
inflammations (its anti-inflammatory effect greatly helps reduce arthritis, rheumatism, gout and other 
inflammations), high cholesterol, boosting the immune system by increasing the production and performance of 
white blood cells and building resistant to various kinds of infections and reducing water retention (Carrot juice, 
2013).  
    
Celery Juice: Celery juice is very low in calories and has no fat, although it is high in vitamin C and 
vitamin A. Celery juice is also high in dietary fiber and a good source of folic acid, potassium, vitamin B-1 and 
vitamin B-6. Although celery juice contains a higher level of sodium than other vegetables juices at 115 
milligrams per serving, the sodium is generally offset by the high levels of potassium. Celery juice has a 
phytochemical compound known as coumarins which may help treat cancer, prevent migraines and lower blood 
pressure. (Nutritional-Value, 2013).  
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Ethical consideration: 
 
Permission to conduct the proposed study was obtained from the head of Oncology and Nuclear 
Medicine unit. Prior to the initial interview, the researchers introduced themselves to patients who met the 
inclusion criteria; each potential patient was fully informed with the purpose and nature of the study, and then an 
informed consent was taken from participants who accept to participate in the study. The researchers emphasized 
that participation in the study is entirely voluntary and withdrawal from the study doesn't affect care provided; 
anonymity and confidentiality were assured through coding the data. 
 
Pilot Study: 
 
Once permission was granted to proceed with the proposed study, a pilot study was carried out on 5 
patients to test the feasibility and clarity of the used tools as well the accessibility of the formula; no tool 
modifications was needed. The sample included in the pilot study was excluded from the final study sample. 
 
Procedure: 
 This study was conducted through two phases preparatory and implementation phase. 
 
Preparatory phase: 
During this phase, approval of Oncology and Nuclear Medicine unit professors about using the formula 
was carried out after discussion of its components, benefits, methods of preparation and preservation. The 
Demographic & Medical Background Assessment Data Sheet was constructed after extensive review of 
literature and discussion of chemotherapy protocols among patients with advanced lung cancer with the 
responsible physicians and nurses at the Oncology and Nuclear Medicine unit. Also the nutritious 
formula/Energy Juice (two medium carrots, one medium beet roots and one root of parsley) make all juice to 
maintain its nutritive value was tested for price and facility to performance. Pilot study was carried out on five 
patients by using (Demographic & Medical Background Assessment Data Sheet and the Revised Piper Fatigue 
Scale (PFS- R13) tools as well the nutritional formula/Energy Juice.  
 
Implementation phase: 
The patients meeting the inclusion criteria were approached individually after admission, the purpose 
and nature of the study, procedures and tools were explained; a written consent was taken from the patients who 
accept to share in the study. Data were collected during the whole academic year (October 2010 to September 
2011). The routine of admission to receive chemotherapy at the Oncology and Nuclear Medicine unit is to take 
blood sample to check hemoglobin, white blood cells count, PT & PTT; if the results are within normal range the 
patient is enrolled to administer chemotherapy at the afternoon shift, consequently the patients recruited in the 
present study were interviewed using the Revised Piper Fatigue Scale (PFS-R13).  
The Assessment Data Sheet (Demographic and Medical Background) were obtained from patients’ file and from 
a member of his/her relative, while the data related to administration of chemotherapy intravenously were 
obtained (WBcs, Hbg) just before receiving the chemotherapy session to prove if the patient was eligible for 
starting the session. This data was recorded as baseline assessment, followed by structured interview through 
which the first reading as a baseline of fatigue by using the Revised Piper Fatigue Scale (PFS-R13) which was 
carried out by the researchers. Then the patients received the chemotherapy at the afternoon shift. And the 
researchers explained to the patients the nature of the formula and how to take it (twice daily on a merely empty 
stomach). 
 
 Knowing that the rehydration phase (increase intravenous fluid and enhance oral fluid) begins after 
chemotherapy administration which takes from five to seven days according to patients' condition; researchers 
advised the participants to avoid taking the ordinary oral beverage/caned juice and replaced it by the 
recommended Energy Juice. A week later and during the morning shift/afternoon shift, the first follow-up 
(second reading); data were collected by using the PFS-R13); Two weeks later the second follow up (third 
reading) was obtained by using the PFS-R13). Finally within three to four weeks later patients are usually 
discharged so the third follow up (Forth/ reading) was carried out (the medical background data were re-
obtained as well the fatigue level using PFS-R13. Over the study period; patients and their caregivers were 
contact with the researches face to face and by the cell phone to communicate at any time in order to reassure 
them and to ensure the using of the formula as well to check the presence of any symptoms/problems. 
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Statistical Analysis: 
 
The collected data were coded and tabulated by using a personal computer. Statistical package for 
social science (SPSS) version 16 was used. Descriptive and Inferential statistics were used to answer research 
questions. Percentage distribution, mean and standard deviation were calculated. In this study t-test was used to 
compare means between fatigue scores, complete blood picture results on admission and prior to discharge, and 
the Pearson correlation coefficients for various factors which may affect fatigue as; age, hemoglobin results, 
white blood count.  Correlations were done to find the relation between fatigue scores & blood test results 
(hemoglobin, WBCs) patient' age, duration of illness and metastasis.  Statistical significance was considered at 
p-value 0.001. 
 
3. Results:  
 
       Findings of this study will be presented in three main sections: I) Description of the study subjects’ 
characteristics (socio-demographic and medical related data). II) Differences between fatigue scores on 
admission and prior to discharge. III) Correlation between fatigue scores and (selected medical responses, 
patients’ age, metastasis occurrence and medication).  
 
I) Description of study subjects’ characteristics: 
 
      The recruited patients in this study were 24 males and 6 females with definite diagnosis of advanced lung 
cancer and treated with chemotherapeutic drugs (Fluorouracil or  platinol).  (Table: 1) showed that the majority 
of the male developed cancer as a primary lesion (83.3%) while female patients developed cancer lung as a 
metastasis from cancer breast. The age of the patients ranged between 20 and 64 years old with mean equal 
39.43 + 12.95, there was approximate equal distribution of patients in relation to age categories. While the 
duration of illness ranged between 6 months and 4 years. Almost two thirds of the patients were receiving 
Fluorouracil (5-FU) (66.7%) and the patients were distributed between the chemotherapeutic cycles in an equal 
manner. 
     
II) Differences between fatigue scores on admission and prior to discharge:  
 
     As regards the comparison of the four total fatigue readings, (table: 2-1) showed that the least total fatigue 
score was observed before administration of chemotherapy (on admission) and the worse fatigue score was 
directly after receiving the chemotherapy in the 1st follow up with 100% was feeling bad; the total fatigue score 
prior receiving chemotherapy was about two thirds (63.3%) of the respondents were less than 110 which means 
feeling good, (0%) in the 1st follow up and again it started to be good with (43.3%)  of patients in the 2nd follow 
up and increased to be (53.3%) before patient discharge; with mean+SD= 109.77+58.39, 166.03+43.18, 
137.03+48.05 & 116.47+52.85 respectively. In relation to fatigue dimensions (table: 2-2) showed that on 
admission the patients were approximately distributed equally over the mild, moderate and severe levels 
however it started to be vary over the follow up readings in relation to the behavioral/severity, affective, sensory 
and cognitive dimensions. Moreover the fatigue scores improved by the last reading among all the fatigue 
dimensions when comparing it with the 1st follow up after receiving the chemotherapy. On the other hand, (table 
2-3) showed that the highest mean of differences was between the 2nd and the 3rd reading= 14.63. And (table 2-
4) showed that there was a perfect statistical significant correlation between the 1st, 2nd, 3rd, 4th total fatigue score 
readings & fatigue dimensions; as all correlations are higher than 0.85 within each fatigue dimension and over 
the four fatigue scale readings. 
   
III) Correlation between fatigue scores and (selected medical responses, patients’ age, metastasis 
occurrence and Medication):  
 
(Table: 3-1): Regarding the correlation between the total fatigue scores among the patients with 
selected medical responses (Hgb, WBCs, duration of illness), patients' age there was a statistical significant 
difference of the total fatigue scores over the four readings except the 1st reading of WBCs and total fatigue 
scores as it was -0.15. However the strongest correlation found with the patients' age specially before patients' 
discharge (4th reading)=0.83. (Table: 3-2) showed moderate correlation between patents' age & (Hgb, WBCs) 
levels specially before patients discharge as it was  -0.65, -0.67 for Hgb & WBCs respectively.  While (table: 3-
3) represented the mean of difference between metastasis occurrence, chemotherapy administration (platinol/5-
FU) & different total fatigue score four readings which showed difference with only metastasis & 1st, 2nd,3rd,4th 
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readings= 3.55, 3.34, 3.89, 4.46 respectively. Moreover (table: 4) showed that 10% in the 4th reading 
experienced fatigue for weeks comparing to 13.3% in the 1st, 2nd,3rd readings. The frequency of factors which 
caused fatigue over the four readings represented that it was 3.3%, 10% & 83.30%  exposure to pollution & 
smoking, activity of daily living (ADL) & receiving chemotherapy respectively. Factors which relieving fatigue 
represented that nothing relieving fatigue were the highest frequency with 56.6% in the 1st reading while it was 
increased to be 73.3% in the 2nd reading. But it was being reduced as 60% & 76.7% in the 3rd & in the 4th reading 
respectively claimed that the given nutritional formula (energy juice) helped them to relieve their fatigue level. 
Moreover 93.2% at the 1st & 4th readings described fatigue as feeling tiredness. Regarding experienced any other 
symptoms; 36.6% in the 4th reading reported that they had regular bowel movements comparing to 3.3% only on 
the 2nd reading; while patients who were suffering from shortness of breath was decreased to be 60% in the 4th 
reading comparing to the 2nd reading which was up to 83.3%.  
 
I) Description of the study subjects’ characteristics (socio-demographic & medical related data). 
 
Table 1- Characteristics of the patients recruited in the study: (n=30). 
 
Characteristics Number Percentage 
Gender 
   Male 
   Female 
 
Age      Mean+SD = 39.43 + 12.95 
   20- 
   30-  
   40-  
   50-64 
 
Duration of illness 
 < 1 year 
  1year>2years 
  2 year>3years 
  3 year≥4years 
 
Cancer type 
   Primary 
   Secondary 
 
Chemotherapeutic agent 
   Fluorouracil (5-FU) 
   Platinol 
 
Chemotherapy cycle 
   1st   
   2nd  
   3rd  
   4th  
 
24 
6 
 
 
9 
8 
7 
6 
 
 
9 
10 
3 
8 
 
 
25 
5 
 
 
20 
10 
 
 
9 
9 
6 
6 
 
80% 
20% 
 
 
30% 
26.7% 
23.3% 
20% 
 
 
30% 
33.3% 
10% 
26.7% 
 
 
83.3% 
16.7% 
 
 
66.7% 
33.3% 
 
 
30% 
30% 
20% 
20% 
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II) Differences between fatigue scores on admission and prior to discharge.  
 
Table 2.1: Total fatigue scores levels among lung cancer patients' receiving chemotherapy on admission, 
1st, 2nd and 3rd follow up; by using the Revised Piper  Fatigue Scale  (PFS-R13):    (n=30). 
   
Total fatigue 
scores levels  
On admission 
 
Mean+SD 
109.77+58.39 
1st Follow up 
A week later 
Mean+SD 
166.03+43.18 
2nd Follow up 
Two weeks later 
Mean+SD 
137.03+48.05 
3rd Follow up 
Before discharge 
Mean+SD 
116.47+52.85 
N             % N               % N             % N            % 
0 - >110    feeling 
good 
19         63.3%  0               0% 13         43.3% 16         53.3% 
110 - ≥ 220  
feeling bad 
11         36.7%  30             100% 17          56.7% 14          46.7% 
 
Table 2-2: Distributions of Piper fatigue scale dimensions on admission, 1st, 2nd and 3rd follow up readings 
(PFS-R13): (n=30). 
 
 
 
 
 
 
Revised Piper Fatigue Scale 
Dimensions 
On 
admission 
Baselnie 
1st Follow 
up 
A week later 
2nd Follow up 
Two weeks 
later 
3rd Follow up 
Before 
discharge 
N % N % N % N % 
Behavioral/ Severity         
  -None (0) 0 0% 0 0% 0 0% 0 0% 
  -Mild (1-3) 17 56.7% 4 13.3% 10 33.3% 11 36.7% 
  -Moderate (4-6) 2 6.6% 12 40% 10 33.3% 17 56.7% 
  -Severe (7-10) 11 36.7% 14 46.7% 10 33.3%   2 6.6% 
Total 30 100 30 100 30 100% 30 100 
Affective         
  -None (0) 0 0% 0 0% 0 0v 0 0% 
  -Mild (1-3) 9 30% 0 0% 0 0% 6 20% 
  -Moderate (4-6) 10 33.3% 8 26.7% 13 43.3% 11 36.7% 
  -Severe (7-10) 11 36.7% 22 73.3% 17 56.7% 13 43.3% 
Total 30 100 30 100 30 100 30 100 
Sensory         
  -None (0) 0 0% 0 0% 0 0% 0 0% 
  -Mild (1-3) 8 26.%7 0 0% 0 0% 8 26.7% 
  -Moderate (4-6) 12 40% 9 30% 13 43.3% 13 43.3% 
  -Severe (7-10) 10 33.3% 21 70% 17 56.7%   9 30% 
Total 30 100 30 100 30 100 30 100 
Cognitive/ Mood         
  -None (0) 0 0% 0 0% 0 0% 0 0% 
  -Mild (1-3) 10 33.3% 0 0% 3 10% 8 26.7% 
  -Moderate (4-6) 11 36.7% 13 43.3% 17 56.7% 14 46.6% 
  -Severe (7-10)   9 30% 17 56.7% 10 33.3% 8 26.7% 
Total 30 100 30 100 30 100 30 100 
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Table 2-3: Mean of difference among patients fatigue scale on 1st (on admission), 2nd, 3rd and 4th readings 
(PFS-R13): (n=30).   
 
Total sheet score 1st & 2nd reading 2nd& 3rd  reading 3rd  & 4th  reading 1st & 4th  reading 
t-test results -8.41* 14.63* 7.28* -1.22 
Sig=0.001* 
 
Table 2-4: Correlation of fatigue dimensions &  the total Piper Fatigue scale (PFS-R13) readings on 
dimension (1st) reading , one week later (2nd) reading, two weeks later (3rd) reading  and before discharge 
(4th) reading: (n=30). 
   
The four (dimensions) fatigue 
sub-scale readings  
1st total Piper 
scale reading 
 
On admission 
2nd total Piper 
scale reading 
 
A week later 
3rd  total Piper 
scale reading 
 
Two weeks later 
4th total  Piper 
scale reading 
 
Before discharge 
Behavior/Severity: 
    -1st reading  
 
0.98* 
 
 
  
    -2nd reading  0.99*   
    -3rd reading   0.98*  
    -4th reading    0.89* 
Affective: 
    -1st reading 
 
0.96* 
   
    -2nd reading  0.96*   
    -3rd reading   0.98*  
    -4th reading    0.92* 
Sensory: 
    -1st reading 
 
0.99* 
   
    -2nd reading  0.96*   
    -3rd reading   0.98*  
    -4th reading    0.93* 
Cognitive/Mood: 
    -1st reading 
 
0.96* 
   
    -2nd reading  0.97*   
    -3rd reading   0.96*  
    -4th reading    0.89* 
Sig=0.001* 
 
III) Correlation between fatigue scores and (selected medical responses, patients’ age, metastasis 
presentation and Medication).  
 
Table 3-1: Correlation between total scores on on 1st (on admission), 2nd 3rd and 4th readings of the Revised 
Piper Fatigue Scale (PFS-R13) and selected medical responses: (n=30).  
 
Total Fatigue 
scores 
Age duration of 
illness 
Hb 
1streading 
On 
admission 
Hb     
2nd reading 
Before 
discharge 
WBCs  
1st reading 
On 
admission 
WBCs  
2nd  reading 
Before 
discharge 
1st   reading 0.60* 0.56* -0.36* ------ -0.15 ------ 
2nd  reading 0.80* 0.47* ------ ------ ------ ------ 
3rd  reading 0.82* 0.51* ------ ------ ------ ------ 
4th  reading 0.83* 0.60* ------ -0.63* ------ -0.50* 
Sig=0.001* 
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Table 3-2: Correlation between patients' age & (hemoglobin, WBCs): (n=30). 
 
Selected medical responses  Age 
-Hemoglobin         (On admission) -0.61* 
-Hemoglobin         (Before discharge) -0.65* 
-WBCs                  (On admission) -0.52* 
-WBCs                  (Before discharge) -0.67* 
Sig=0.001* 
 
Table 3-3: Mean of difference of (metastasis, chemotherapy medications) & total fatigue score: (n=30). 
Total Fatigue scores Metastasis 
(yes/No) 
Independent t-test 
Chemotherapy medication 
(Platinol/5-FU) 
Independent t-test 
   1st  reading   (On admission) 3.55* 0.40 
   2nd reading   (A week later) 3.34* 0.58 
   3rd  reading   (Two weeks later) 3.89* 0.73 
   4th  reading   (Before discharge) 4.46* 1.03 
Sig=0.001* 
 
Table 4: Distribution of the patients' responses to additional qualitative items of fatigue Piper scale (PFS-
R13): (n=30) .   
 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
29 
Discussion: 
 
      This research presents findings related to the effect of nutritional formula (Energy Juice) on fatigue among 
patients with advanced lung cancer receiving chemotherapy only. Patients with co-morbid diseases were 
excluded from the study in order to control their possible impact on fatigue. 
In relation to the 1st research question(s); results of this research showed that the study subjects’ characteristics 
go in accordance with the incidence of the disease as the majority of the patients were male, ex. smokers, their 
working were workers, drivers, farmers and teachers, and they were suffering from primary lesion of cancer 
lung. On the other hand the minority of the sample were female, housewives and developed cancer lung as 
secondary metastasis; after cancer breast. More than one third of the sample was from Gizza-Egypt. The age of 
the respondents ranged between 20-64 years with mean of 39.43 + 12.95 years as well as there was nearly 
approximate equal distribution of patients in relation to age categories and the higher distribution of male 
patients was among the younger age group i.e. between 20 up to 50 years old and the female age was at the age 
of 60 up to 64. This results contradicts the findings of  Youlden , Cramb and Baade (2008) who found that 
cancer lung rarely occurs before the age of 50 years, after which incidence rates increase with age to peak at 70-
79 years for males and females.  
 
In relation to the duration of illness, Most of the sample (almost two third) suffered from lung cancer 
illness between 2 months up to 24 months; while the rest exceeded the 24 months up to 48 months. The majority 
of the sample was suffering from primary cancer. Two third of the sample was undertaken flurouracil (5-FU) 
treatment and was either between first or second chemotherapy cycle. This finding goes with Alaa; etal (2010) 
who observed that none of the patients exceeded five years survival. He stated that the majority of patients with 
lung cancer are diagnosed at a late stage and, 15% survive 5 years. Second, risk paradigms are changing, from 
smoking only to occupational, environmental or home carcinogens to the risk associated with premalignant 
airway changes. Third, advances in early diagnostic options have the potential to discover lung carcinoma while 
still in a preinvasive stage, minimally invasive stage or as small peripheral nodules.  Moreover this study found 
that all the patients recruited in the study experienced fatigue with different levels which congruent with Cancer 
Research UK (2012) which revealed that one hundred percent of the patient experienced fatigue for patient with 
lung cancer. And they added that chemotherapy was the main treatment for small cell lung cancer as it can help 
to shrink or slow the growth of locally advanced or metastatic NSCLC. It can also help to control symptoms for 
some people. The drug of choice to treat cancer lung based on their study was cisplatin.  
 
Fatigue is a near universal problem that affects approximately three quarters or more of the people and 
it is the most common side effect of cancer experience. Fatigue affects more than half of the people on most 
days, and it affects their daily lives (ICC 2008). On the other hand, Morrow (2007) clarified that fatigue has both 
subjective and objective components and may involve dysfunctions in physical symptoms (physical weakness or 
tiredness), mood (depression), motivation (lack of initiative or motivation), cognition (impairment of cognitive 
function), and social functions (reduced ability to sustain social relationships). Cancer-related fatigue is the most 
common side effect of cancer and cancer treatment. Research suggests that anywhere between 70% and 100% of 
cancer patients getting treatment have fatigue. And about 30% to 50% of cancer survivors have said that their 
fatigue lasts for months or even years after they finish treatment (American Cancer Society,2012). Moreover 
fatigue often begins before the cancer is diagnosed, typically increases during the course of cancer treatment, and 
then declines somewhat but persists at a higher than baseline rate after treatment is completed 
(Andrews, Morrow GR,Roscoe et al. In: Arms, Meinir, Higginson; 2004).  
In the current study it was observed that fatigue increased after receiving chemotherapy (2nd reading) 
than on admission. So chemotherapy defiantly induced more fatigue among the recruited patients. Table (2-1) 
Shows that among fatigue score it was observed that the best result was prior taking the chemotherapy as almost 
two third of the sample was feeling good as they was only suffering from cancer pain (if it is existed) as some of 
them has no pain, however once the chemotherapy cycle started patients fatigue experience increased; as all of 
them there feeling was bad based on the (1st follow up) 2nd reading; inspite of starting taking the nutritious 
formula. But effect of the formula detected from the third reading through the forth reading as patients' fatigue 
experience improved gradually, even many of those patients reported that they can do their activity of daily 
living better than before and even constipation problem which they had before has been solved. Moran, (2011) 
reported that fatigue often occurs due to less than optimal dietary habits, and patient can help fight fatigue with 
root vegetables. She added that Carrots are the most popular and widely available root vegetable which fight 
fatigue. Moreover Beetroot are rich in vitamins A, B1, B2, B6, folic acid B12 and C. Some of their many 
mineral properties are folic acid, potassium, calcium, sodium, magnesium, iron, phosphorus and many 
antioxidants. The pigment betacyanin, which is responsible for the beet's deep, red-magenta color is also a 
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powerful antioxidant. Moreover Frenszi, 2011 mentioned that mix carrots with beet roots are effective as non-
pharmacological management for cancer patient treatment. 
 
Moreover the (table: 2-2) showed that on admission the patients were approximately distributed equally 
over the mild, moderate and severe levels except the behavioral dimension; however it started to be vary starting 
from the 1st follow up reading; specially the affective & the sensory dimension as most of the sample deviated to 
the severe level in both mentioned dimensions; while it started to be almost distributed in a balance way over the 
four dimensions in the last reading. Inspite that none of the recruited sample has zero reading over the fatigue 
rating scales (0 to 10); which reflected that all of them were suffering from fatigue over the four readings in 
different distributions but it was noticed that severity of fatigue over the four dimensions was reduced by the last 
reading in other word this was after taking the nutritional formula almost over 3/4 weeks. In addition the 
researchers found that the highest mean of difference was observed between the second and the third total PFS 
score (table 2-3) which gave explanation that improvement of fatigue generally takes time until the nutritional 
formula (Energy juice) antioxidants has an effect on the fatigue improvement and a strong correlation was 
observed between all four fatigue dimensions (behavior/severity, affective, sensory, cognitive) and the total PFS 
scale score (table 2-4) which gave an indicator that each dimension played a vital role in the overall patient 
fatigue degree. The researchers added that obviously if controlling of any fatigue dimensions achieved; this 
would cause strong positive impact on the overall fatigue score/outcome in general. 
 
 Accordingly the researchers can be answered by (yes) there was a difference between higher scores of 
fatigue score after receiving chemotherapy & lower fatigue score after administration of the nutritional formula 
(Energy Juice). Despite the availability of some treatment options and a great deal of ongoing research, fatigue is 
nevertheless often viewed by clinical staff, caregivers, and the patients themselves as an inevitable consequence 
of cancer and cancer treatment. (Stone, Richardson, Ream et al.; 2000). Adding calories by doubling or tripling 
fruit intake among lung cancer survivors using this same type of intervention might offer important extra 
benefits in maintaining body weight and improving well-being as the possible effects on lung cancer prognosis 
are being assessed. (BYERS, 2008): Cisplatin/platinol side effects; was found that the most common problems 
experienced during cisplatin therapy and overdosage include nephrotoxicity, electrolyte disturbances, myelo 
suppression, neurotoxicity, anaphylactic reactions, and ototoxicity. Side effects with cisplatin include: fatigue: - 
this is the most common cisplatin side effect and can last several weeks or months after treatment are completed. 
Some people experience shortness of breath. Nausea from cisplatin can be severe; however anti-nausea 
medicines can significantly reduce this cisplatin side effect. Kidney damage can occur with cisplatin treatment. 
The best way to reduce the side effects of cisplatin is to vitamin E (Sahelian) expert in nutrition and dietary 
supplement. And this research finding congruent with the current research finding (table: 4) as the majority of 
the studied sample experienced shortness of breath in the 2nd reading but it was improved gradually to be almost 
reduced to two third only of the sample before patients' discharge and after taking the (energy juice) for almost 
one month twice daily. 
 
In relation to the 2nd research question(s); Regarding the selected medical responses; it was found that 
generally in the first hemoglobin measurement comparing to the last measurement was either between below 
normal or on border normal (7-11) g/dl, and this expected because of chemotherapy side effects as well as 
excessive vomiting and malnutrition, this finding supported by European Cancer Anaemia Survey (ECAS), as a 
study conducted across 24 nations in Europe, reported that about 83% of patients who received chemotherapy 
demonstrated anemia [defined as a hemoglobin (Hb) < 12.0 g/dL] (Barrett-Lee et al., 2006). Moreover Anemia 
often increases symptoms such as fatigue, weakness, and dyspnea; thus, it may worsen quality of life and 
performance status in cancer patients (Bremberg, Brandberg, Hising, Friesland, & Eksborg, 2007; Kosmidis & 
Krzakowski, 2005). While the researchers found that WBCs remains within normal regarding the two 
measurements (on admission & before discharge) and this gave an indicator that the health team may be 
concerned more about the immunity indicator rather than any other indicators and WBCs might take more time 
to be affected than Hgb. On the other hand the researchers claimed that the nutritional formula might play a vital 
role in maintaining patients' immunity. A research conducted by Komorizono, Kohara, Oketani, Maeda & 
Shibathou (2003) which aimed to evaluate the efficacy and adverse events of systemic combined chemotherapy 
with low dose of 5-fluorouracil, the study revealed a contrary result as patients' complicated by leukocytopenia. 
 
Moreover, factors affecting fatigue result, table (3-3) was observed that patients with no metastasis their 
fatigue score was better whereas there was no difference between patients who were undertaking flurouracil or 
platinol treatment regarding fatigue score. On the other hand in relation of taking the nutritious formula it was 
found that duration of illness and also different ages affect the fatigue score as one third of the sample ranged 
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between 20 to 30 years old that might explain that there was a relation between the fatigue score and patients age 
as much as age increased the fatigue scores becomes bad. Vertuani, Silvia; Angusti, Angela; Manfredini, Stefano 
(2004) revealed that the action of one antioxidant may depend on the proper function of other members of the 
antioxidant system. The amount of protection provided by any one antioxidant will also depend on its 
concentration, its reactivity towards the particular reactive oxygen species being considered, and the status of the 
antioxidants with which it interacts, so age could play a role to specify the antioxidant food amount for patients.  
 
The following finding was expected as there was a correlation between Hgb, WBCs and patients age as 
cells formation/replacement became slower as much as human became older so aged patients might need more 
attention and even boost the nutritious formula to get more improvement. Tables (3-1 & 3-2) highlighted the 
effect of the nutritional formula (Energy Juice) on the selected medical responses (Hemoglobin & WBCs) as 
correlations in relation to fatigue scores improved gradually and it was clear at the last Hgb reading (before 
patients discharge) & total fatigue score. Researchers claimed the improvement of fatigue as a result of 
antioxidants formula in the nutritional formula  (Energy Juice) which  played a gradual vital role on the 
improvement of hemoglobin level as antioxidant cleaning up the blood from harmful circulated substances and 
gives chance to hemoglobin cells production to be healthy; specially for those patients  who were suffering from 
cancer lung which duplicate the negative fatigue impact as in addition to chemotherapy side effects on 
hemoglobin formation; the cancer lung played a role to interfere against gas exchange process. Moreover the 
researchers found a relation between patients' age who undertaken chemotherapy and (PFS-R13) total score 
result specially the reading before patients discharge which showed a perfect correlation which reflected that; 
inspite (PFS-R13) score affected by patients' age but it showed improvement resulted of using the energy juice 
twice daily over a month. Parallel finding was noticed regarding correlation between the (PFS-R13) total score 
readings and duration of illness which validate the positive effect of the nutritional juice specially before patients 
discharge.  
 
On the other hand WBCs was within normal range from the beginning of the research which helped the 
body to control and get rid of the microorganisms and harmful circulated substances and compacted fatigue 
much better. In addition (table 4) and based on coding of the qualitative finding the researchers reported that one 
third of the sample reported that their fatigue feeling generally reduced to be only few minutes comparing to the 
second reading. Moreover majority of the patients claimed that factor which directly contributing or causing 
respondents fatigue was receiving chemotherapy. And they added that the best thing they have found to relieve 
their fatigue was the nutritional formula (Energy Juice) as almost most of them reported that. And the majority of 
them over the four readings described fatigue as tiredness. To conclude the nutritional formula (Energy Juice) 
had an observable positive effect on the improvement of fatigue for patient with lung cancer receiving 
chemotherapy but medical responses as (WBCs, Hg…etc) need more attention and further studies in relation to 
the nutritional formula & cancer lung. 
 
Conclusion: 
 Patients with lung cancer experienced fatigue with different levels. Chemotherapeutic agents increase 
fatigue severity. Nutritional formula (Energy Juice) decrease fatigue scores among patient with cancer lung 
receiving chemotherapy. 
 
References: 
• Abdel Raouf H. & Hashem H., (2005). Patients-Health Care Providers Prioritization of The Symptoms 
Experienced By Patients Receiving Chemotherapy. Published in scientific conference of El-Mansoura 
University-Egypt. 
 
• ABID  Larbi, Lung cancer around the World and Arab countries AMAAC Workshop, Algiers 
November, 19, 2011  Lung- Cancer- world- Arab- Countries. 
 
• Abo Daif, H.(2004). Correlates of Fatigue among Patients with Chronic Airway Limitation- 
Unpublished Master Thesis, Faculty of Nursing, Cairo University-Egypt. 
 
• Ahlberg, K., Ekman, T., Gaston-Johansson, F., and Mock, V. Assessment and Management of 
Cancerrelated Fatigue in Adults. The Lancet, 362: 640-650, 2003. 
 
• Alaa, M. ,etal.,(2010) Risk of Lung Cancer in Patients with Preinvasive  Bronchial Lesions Followed by 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
32 
Autofluroscence  Bronchoscopy  and Chest Computed Tomography ,Egyptian Journal of Bronchology 
Vol. 4, No. 1, June, 2010. 
 
• Amen  K, How to fight fatigue in patients with cancer, American Nurse Today  June,2010.Vol.5,No.6 
http//www. americannursetoday.com/default.aspx. 
 
• American Cancer Society, Fatigue in People with Cancer, The American Cancer Society reported that 
there is insufficient evidence to provide specific dietary recommendations for patients with breast, 
colorectal, lung, and prostate cancer.(44), available at   last revised at 12/10/2012. www.cancer.org. 
 
• American Cancer Society. World Health Organization.  Global Cancer Facts & Figures 2nd Edition. 
Atlanta: American Cancer Society; 2011. 
 
• American Cancer Society. World Health Organization.  Global Cancer Facts & Figures 2nd Edition. 
Atlanta: American Cancer Society; 2012. 
 
• Andrews PLR, Morrow GR,Roscoe JA, et al. Mechanisms and models of fatigue associated with cancer 
and its treatment. In: Arms J, Meinir K,Higginson I, editors. Fatigue in Cancer. Oxford: Oxford 
University Press; 2004. p. 51-87.) 
 
• AnnunziataM. A.,Muzzatti B., Mella S., Narciso D., Giacalone A., Fratino L., Tirelli U. , The Revised 
Piper Fatigue Scale (PFS-R) for Italian cancer patients: a validation study, Tumori a journal of 
experimental and clinical oncology 2010/2 E-mail: tumori@istitutotumori.mi.it 
 
• Barrett-Lee, P. J., Ludwig, H., Birgegard, G., Bokemeyer, C., Gascon, P., Kosmidis, P. A., et al. (2006). 
Independent risk factors for anemia in cancer patients receiving chemotherapy: Results from the 
European cancer anaemia survey. Oncology, 70(1), 34-48. 
 
• Bremberg, E. R., Brandberg, Y., Hising, C., Friesland, S., & Eksborg, S. (2007). Anemia and quality of 
life including anemia-related symptoms in patients with solid tumors in clinical practice. Medical 
Oncology, 24(1), 95-102. 
 
• BYERS,T.(2008): Nutrition and Lung Cancer Lessons from the Differing Effects of Foods and 
Supplements, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 
VOL 177,pp470-1. 
 
• Cancer Research UK: Cancer Help UK available at  www.cancarresearchul.org  Updated: 10 December 
2012. 
 
• Cancer Research UK: The safety of vitamins and diet supplements. CancerHelp UK available at 
www.cancarresearchul.org  Updated: 31 December 2012. 
 
• Carroll JK, Kohli S, Mustian KM,et al. Pharmacologic treatment of cancer-related fatigue. The 
Oncologist 2007;12 suppl 1:43-51. 
 
• Carrot juice, Carrot juice blends, benefits  of Carrot juice, Carrot juice, suppliers, exporters, India-
Google chrome 22/3 2013. 
 
• Cella D, Davis K, Breitbart W, et al. Cancer-related fatigue: Prevalence of proposed diagnostic criteria 
in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-3391. 
 
• Clark PC, Ashford S, Burt R, Aycock DM, Kimble LP. Factor analysis of the Revised Piper Fatigue 
Scale in a caregiver sample .J Nurs Meas.2006 Fall; 14(2):71-8.). 
 
• Clark PC, Ashford S, Burt R, Aycock DM, Kimble LP: Factor analysis of the Revised Piper Fatigue 
Scale in a caregiver sample.J Nurs Meas. 2006 Fall; 14(2):71-8. Abstract. 
 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
33 
• Coleman E. Reap the Benefits of Beetroot Juice — Evidence Suggests It Improves Heart Health and 
Athletic Performance, Today’s Dietitian. Vol. 14 No. 2 P. 48 February 2012 Issue. 
 
• Collado-Hidalgo A, Bower JE, Ganz PA et al. Inflammatory biomarkers for persistent fatigue in breast 
cancer survivors. Clin Cancer Res 2006; 12(9): 2759–2766. 
 
• Collin S, de Voge-Voogt E, Visser A, van der Heide Al: Presence, communication and treatment of 
fatigue and pain complaints in incurable cancer patients. Patient Educ Couns, 72: 102-108, 2008. 
 
• Connell S, CARROT JUICE FOR CANCER, 2011. livestrong (Article reviewed by JPC Last updated 
on: Mar 18, 2011). 
 
• Dittner AJ, Wessely SC, Brown RG: (2004).The assessment of fatigue: A practical guide for clinicians 
and researchers. J Psychosom Res, 56: 157-170. 
 
• Eldridge L, National Nutrition Month - Tips for Eating with Lung Cancer, About.com Guide, available 
at http://lungcancer.bout.com/bio/- Lynne- Eldridge March 26, 2009. 
 
• Evans & Agro, Copyright 2010-2013 juicing-benefits-toolbox.com. 
 
• Evans K. Benefits of Beet Juice Exceed Expectations .available at Natural News.com Thursday, 
January 07, 2010. 
 
• Fan HG, Houe´ de´ -Tchen N, Yi QL et al. Fatigue, menopausal symptoms, and cognitive function in 
women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective 
controlled study. J Clin Oncol 2005 23(31): 8025–8032. 
 
• Ferenczi A. (2011) successfully treated cancer patients with either raw beet roots or juiced. 
http://allonhealth.com/beetroot-juice/index.htm.   
 
• Ferenczi A. (2011) successfully treated cancer patients with either raw beet roots or juiced. 
http://allonhealth.com/beetroot-juice/index.htm.  
 
• Gutstein HB. The biologic basis of fatigue. Cancer 2001; 92 (6 Suppl): 1678–1683. 
 
• Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the 
scale of the problem. The Oncologist. 2007; 12 suppl 1:4–10. [PubMed: 17573451]. 
 
• Intercultural Cancer Council( ICC) .Fatigue & Cancer, Fact Sheet, 19 nov. 2008: Email: 
info@iccnetwork.org • Website: http://iccnetwork.org. 
 
• Iop,A, Manfred A M, &  Bonura S: (2004) Fatigue in cancer patients receiving chemotherapy: an 
analysis of published studies Annals of Oncology 15: 712–720.  
 
• Jacobsen, P.B., Haan, D.M., Azzarello, L.M., Horton, J., Balducci, L., and Lyman, G.H. Fatigue In 
Women Receiving Adjuvant Chemotherapy for Breast Cancer: Characteristics, Course, and Correlates. 
Journal of Pain and Symptom Management, 18(4): 233-242, 1999. 
 
• Jean-ierre P, Mustian K, Kohli S, et al. Community-based clinical oncology research trials for cancer-
related fatigue. J Support Oncol 2006;4:511-516. 
 
• Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011), Global cancer statistics. 
CA: A Cancer Journal for Clinicians, 61: 69–90. doi: 10.3322/caac.20107. 
 
• Komorizono Y, Kohara K, Oketani M, Maeda M, Shibathou T (2003). Systemic combined 
chemotherapy with low dose of 5-fluorouracil, cisplatin, and interferon-alpha for advanced 
hepatocellular carcinoma: a pilot study. Digestive Diseases and Sciences (2003)  Volume: 48, Issue: 5, 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
34 
Pages: 877-881. 
 
• Kosmidis, P., & Krzakowski, M. (2005). Anemia profiles in patients with lung cancer: What have we 
learned from the European cancer anaemia survey (ECAS)? Lung Cancer, 50(3), 401-412. 
 
• Lung cancer, fatigue and loss of appetite: Cancer Research UK (2012): Cancer Help UK available from 
www.cancerresearchuk.org. 
 
• Medicine Net.com. (2013). Cancer related fatigue –causes and combating fatigue related to cancer 
available at www.medicinenet.com/script/main/hp.asp march,19. 
 
• Mock, v. (2004) Evidence-Based Treatment for Cancer-Related Fatigue JNCI Monographs vol. 2004, 
issue 32, 112-118 
 
• Monson; October 2008 eMedTV; Benefits of Vitamin A;   http://www.livestrong.com/article/532231-
the-nutritional-value-of-juiced-carrots-beets-apple-and-celery/#ixzz2Abok3VMN. 
 
• Morrow G.: Cancer-Related Fatigue: Causes, Consequences, and Management,          The 
Oncologist May 2007 vol. 12 Supplement 1 1-3. 
 
• Morrow GR, et al. Management of cancer-related fatigue. Cancer Invest 2005;23:229-239.Medline. 
 
• National Cancer Institute. US National institute of Health, 2010. 
http://www.cancer.gov/cancertopics/pdq/supportivecare/fatigue/patient/allpages. 
 
• National Comprehensive Cancer Network and the American Cancer Society. Cancer-Related Fatigue 
and Anemia Treatment Guidelines for Patients (version II). Atlanta, 2003. 
 
• National Comprehensive Cancer Network and the American Cancer Society. Cancer-Related Fatigue 
and Anemia Treatment Guidelines for Patients (version II). Atlanta, 2003. 
 
• National Comprehensive Cancer Network Fighting Cancer Fatigue 2012 (18/3/2013) html. 
 
• National Comprehensive Cancer Network Practice Guidelines. Cancer-Related Fatigue Panel 2004 
Guidelines, version 1.2004, March. Rockledge (PA): National Comprehensive Cancer Network. 
available at http://www.nccn.org. 
 
• Natural health remedies & Alternative medicine articles, 2010. MIRACLES OF CARROT JUICE – 
benefits of carrot juice in nature cure treatment.http://www.naturalhealthcure.org/therapies/the-
miracles-of-carrot-juice.html. 
 
• NCCN Clinical Practice Guidelines in Oncology: Cancer related fatigue. V.I. 2009, available from 
http://www.nccn.org/professionals/physician_gls/PDF/-fatigue.pdf. 
 
• Nelson October2010; MayoClinic.com; Juicing: What are the Health Benefits?;  
http://www.livestrong.com/article/532231-the-nutritional-value-of-juiced-carrots-beets-apple-and-
celery/#ixzz2AbnJH0Os. 
 
• Nutritional-Value-of-juiced-carrots-beets-apple-andcelery/#ixzz2ShiQlU00 
http://www.livestrong.com/article/532231-   retrieved at 2013.  
 
• Opptiz (2008), www.agriculturalproductsindia.com/ Agro/resources.html. 
 
• Parker KP, Bliwise DL, Ribeiro M et al. Sleep/wake patterns of individuals with advanced cancer 
measured by ambulatory polysomnography. J Clin Oncol 2008; 26(15): 2464–2472. 
 
• Piper BF, Borneman T, Sun VC, Koczywas M, Uman G, Ferrell B, and James RL: Cancer-related 
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.16, 2014 
 
35 
fatigue: role of oncology nurses in translating National Comprehensive Cancer Network assessment 
guidelines into practice. Clin J Oncol Nurs, 12: 37-47, 2008. 
 
• Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper 
            Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum.     
           1998 May;25(4):677-84. 
 
• Presley, et al.; January 2011“Nitric Oxide: Biology and Chemistry”; Acute Effect of a High Nitrate Diet 
on Brain Perfusion in Older Adults; T.D. http://www.livestrong.com/article/532231-the-nutritional-
value-of-juiced-carrots-beets-apple-and-celery/#ixzz2AbouhCMh. 
 
• Ramadan A., Lung Cancer Awareness Month commemorated in Egypt,  Egypt Independent, Can 
Survive symposium, 7/2/2012. 
 
• Salim E, Jazieh A and Moore M (2011). Lung Cancer Incidence in the Arab League Countries: Risk 
Factors and Control. Asian Pacific Journal of Cancer Prevention, 12, 17-34.  
 
• Scott HR, McMillan DC, Brown DJ et al. The systemic inflammatory response, weight loss, 
performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 
2002; 87(3): 264–267. 
 
• Servaes, P., Verhagen, S., and Bleijenberg, G. Determinants of Chronic Fatigue in Disease-free Breast 
Cancer Patients: A Cross-sectional Study. Annals of Oncology, 13: 589-598, 2002. 
 
• Stone P, Richardson A, Ream E,et al. Cancer-related fatigue: Inevitable, unimportant, and untreatable? 
Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000;11:971-975). 
 
• Strohschein FJ, Kelly CG, Clarke AG, Westbury CF, Shuaib A, Chan KM., 2003. Applicability, 
validity, and reliability of the Piper Fatigue Scale in postpolio patients. 
 
• Vertuani, Silvia; Angusti, Angela; Manfredini, Stefano (2004). "The Antioxidants and Pro-Antioxidants 
Network: An Overview". Current Pharmaceutical Design 10 (14): 1677–94. 
doi:10.2174/1381612043384655. PMID 15134565. 
 
• Whitney-Chavez E, Sep 2, 2011,  The Nutritional Value of Juiced Carrots, Beets, Apple and 
Celery http://www.livestrong.com/article/532231-the-nutritional-value-of-juiced-carrots-beets-apple-
and-celery/#ixzz2Shiryn1c Article reviewed by Jenna Marie Last updated on: Sep 2, 2011. 
 
• World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical 
activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for 
Cancer Research; 2007. 
 
• Youlden, Danny R.; Cramb, Susanna M.; Baade, Peter D. The International Epidemiology of 
            Lung Cancer: Geographical Distribution and Secular Trends. Journal of Thoracic Oncology, 
           2008, Vol. 3, pp 819-831. 
 
 
 
 
